Voyageur Pharmaceuticals (TSE:VM)

:VM

Voyageur Pharmaceuticals

RESEARCH TOOLSreports

Voyageur Pharmaceuticals (VM) Price & Analysis

Compare

20 Followers

VM Stock Chart & Stats

C$0.17

>-C$0.01(-5.56%)

At close: Jan 08 4:00 PM EST

C$0.17

>-C$0.01(-5.56%)

Day’s Range― - ―

52-Week RangeC$0.10 - C$0.36

Previous CloseN/A

Volume12.11K

Average Volume (3M)72.03K

Market Cap

C$21.43M

Enterprise ValueC$20.51M

Total Cash (Recent Filing)C$943.15K

Total Debt (Recent Filing)C$40.00K

Price to Earnings (P/E)―

Beta-0.67

Next Earnings

Apr 24, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding178,586,980

10 Day Avg. Volume61,621

30 Day Avg. Volume72,034

Financial Highlights & Ratios

PEG Ratio-0.33

Price to Book (P/B)19.88

Price to Sales (P/S)0.00

P/FCF Ratio-29.59

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Voyageur Pharmaceuticals News

Voyageur Pharmaceuticals Launches Up to $7.5 Million Private Placement to Advance Contrast Media Projects

Voyageur Pharmaceuticals ( ($TSE:VM) ) has provided an announcement. Voyageur Pharmaceuticals has launched a non-brokered private placement to...

5d ago

Voyageur Advances Vertically Integrated Barium and Iodine Contrast Media Strategy

An update from Voyageur Pharmaceuticals ( ($TSE:VM) ) is now available. Voyageur Pharmaceuticals has outlined a strategic roadmap...

14d ago

Voyageur Confirms High-Purity Barite, Advances to Health Canada Trial

Voyageur Pharmaceuticals ( ($TSE:VM) ) has shared an update. Voyageur Pharmaceuticals has confirmed that barium sulfate sourced from...

26d ago

Voyageur Pharmaceuticals Secures Bayer Collaboration to Advance Iodine Contrast Supply

The latest update is out from Voyageur Pharmaceuticals ( ($TSE:VM) ). Voyageur Pharmaceuticals has signed a collaboration and...

1M ago

Voyageur Pharmaceuticals Gains Full Control of Iodine Technology, Names New Director of Chemistry

Voyageur Pharmaceuticals ( ($TSE:VM) ) has issued an update. Voyageur Pharmaceuticals has secured 100% ownership of the proprietary...

3M ago

Voyageur Pharmaceuticals Strengthens Board for U.S. Expansion

Voyageur Pharmaceuticals ( ($TSE:VM) ) has provided an announcement. Voyageur Pharmaceuticals Ltd. has appointed Virginia Alling as an...

5M ago

Voyageur Pharmaceuticals Expands into Mexican Market with Phalanx Partnership

Voyageur Pharmaceuticals ( ($TSE:VM) ) has issued an announcement. Voyageur Pharmaceuticals has signed a non-exclusive distribution agreement with...

5M ago

Voyageur Pharmaceuticals Expands Board with Wall Street Experts for U.S. Market Growth

The latest announcement is out from Voyageur Pharmaceuticals ( ($TSE:VM) ). Voyageur Pharmaceuticals Ltd. has expanded its board...

5M ago

Voyageur Pharmaceuticals Initiates U.S. Iodine Feasibility Study for Integrated Manufacturing

Voyageur Pharmaceuticals ( ($TSE:VM) ) has issued an update. Voyageur Pharmaceuticals has launched a U.S.-based iodine feasibility study...

7M ago

Voyageur Pharmaceuticals Launches First Commercial Shipments of Barium Contrast Products in Canada

Voyageur Pharmaceuticals ( ($TSE:VM) ) just unveiled an update. Voyageur Pharmaceuticals has initiated its first commercial shipments of...

7M ago

VM FAQ

What was Voyageur Pharmaceuticals’s price range in the past 12 months?

Voyageur Pharmaceuticals lowest stock price was C$0.10 and its highest was C$0.36 in the past 12 months.

What is Voyageur Pharmaceuticals’s market cap?

Voyageur Pharmaceuticals’s market cap is C$21.43M.

When is Voyageur Pharmaceuticals’s upcoming earnings report date?

Voyageur Pharmaceuticals’s upcoming earnings report date is Apr 24, 2026 which is in 25 days.

How were Voyageur Pharmaceuticals’s earnings last quarter?

Currently, no data Available

Is Voyageur Pharmaceuticals overvalued?

According to Wall Street analysts Voyageur Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Voyageur Pharmaceuticals pay dividends?

Voyageur Pharmaceuticals does not currently pay dividends.

What is Voyageur Pharmaceuticals’s EPS estimate?

Voyageur Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Voyageur Pharmaceuticals have?

Voyageur Pharmaceuticals has 178,586,980 shares outstanding.

What happened to Voyageur Pharmaceuticals’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Voyageur Pharmaceuticals?

Currently, no hedge funds are holding shares in TSE:VM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.